Literature DB >> 9629490

Quantification of the variation due to lysing technique in immunophenotyping of healthy and HIV-infected individuals.

R Pacifici1, P Zuccaro, A Cozzi-Lepre, S di Carlo, A Bacosi, A Fattorossi.   

Abstract

OBJECTIVE: We performed a side-by-side comparison between three stain-then-lyse commercially available methods (Ortho-mune Lysing solution, FACS lysing solution and ImmunoPrep reagent system) and a lyse-then-stain method using hypotonic NH4Cl. The major difference between these methods is that only in the latter the aliquots of sample to be distributed into diverse tubes for the various antibody combinations were obtained from a lysis step performed in the same tube. DESIGN AND METHODS: Lymphocytes from 20 healthy and 20 HIV+ subjects were phenotyped by dual color flow cytometry using a standard procedure that included the establishing of a lymphocyte gate on light scatter bit map and the use of the minimal acceptable antibody combinations, i.e., CD45/CD14, CD3/CD4 and CD3/CD8, according to CDC recommendations. All samples were processed in triplicate to assess tube-to-tube variability.
RESULTS: In healthy subjects, erythrocytes pre-lysing provided the highest purity and recovery in the lymphocyte gate, and allowed the best identification of CD4+ lymphocytes. Most remarkably, erythrocytes pre-lysing significantly outdid all other methods in reducing tube-to-tube variability. This allowed the attainment of highest correlation between CD3+ cells identified by CD3/CD4 and CD3/CD8 antibody combinations and the minimum variability between the sum of the %CD3+CD4+ and %CD3+CD8+, and the total %CD3+. This higher reliability of the pre-lysis method was particularly evident with HIV+ patients in which the lymphocyte gate was often and unpredictably contaminated by debris and other cell types.
CONCLUSIONS: The present study demonstrates that lysing erythrocytes in a single tube and distributing aliquots of lysed blood into different tubes for the various antibody combinations provides superior results for routine immunophenotyping.

Entities:  

Mesh:

Year:  1998        PMID: 9629490     DOI: 10.1016/s0009-9120(98)00011-3

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Francesca Ciaraffa; Giovanni Scambia; Amelia Evoli
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

2.  Range-reference determination of lymphocyte subsets in Moroccan blood donors.

Authors:  N Touil; R Hadef; A Lemnouer; A Zrara; A I Sbai; B Belfquih; S Mrani; A Benkirane; M Ouaaline; M Mrabet
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

3.  A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects.

Authors:  Xuanhong Cheng; Daniel Irimia; Meredith Dixon; Kazuhiko Sekine; Utkan Demirci; Lee Zamir; Ronald G Tompkins; William Rodriguez; Mehmet Toner
Journal:  Lab Chip       Date:  2006-11-24       Impact factor: 6.799

4.  Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.

Authors:  Andrea Fattorossi; Alessandra Battaglia; Alexia Buzzonetti; Giacomo Minicuci; Raffaella Riso; Laura Peri; Giovanni Scambia; Amelia Evoli
Journal:  J Clin Immunol       Date:  2007-11-14       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.